Pharmaceuticals (12) | Equity Distribution Agreements (12)
Browse by Company
Recent Contracts
-
Amendment No. 1 to the Equity Distribution Agreement, dated March 26, 2021, by and between Aquestive Therapeutics, Inc. and Piper Sandler & Co
(Aquestive Therapeutics, Inc., Filed With SEC on March 26, 2021)
-
Letter amending the Standby Equity Distribution Agreement by and between the Institutional Investor and Acreage Holdings, Inc., dated March 11, 2021
(Acreage Holdings, Inc., Filed With SEC on March 26, 2021)
-
Equity Distribution Agreement, dated December 1, 2020, by and between the Company and Canaccord Genuity
(ORAMED PHARMACEUTICALS INC., Filed With SEC on December 1, 2020)
-
Equity Distribution Agreement by and among the Company and Maxim Group LLC dated as of April 13, 2020
(ARTELO BIOSCIENCES, INC., Filed With SEC on April 15, 2020)
-
Amendment to the Equity Distribution Agreement, dated February 10, 2020, between Canaccord Genuity LLC and Oramed Pharmaceuticals Inc
(ORAMED PHARMACEUTICALS INC., Filed With SEC on April 6, 2020)
-
Equity Distribution Agreement, dated as of March 6, 2020, between VIVUS, Inc. and Piper Sandler & Co
(VIVUS INC, Filed With SEC on March 6, 2020)
-
Amendment to the Amended and Restated Equity Distribution Agreement, dated October 2, 2019
(Cocrystal Pharma, Inc., Filed With SEC on January 29, 2020)
-
Amended and Restated Equity Distribution Agreement, dated October 30, 2019
(Cocrystal Pharma, Inc., Filed With SEC on October 30, 2019)
-
Equity Distribution Agreement, dated September 5, 2019, by and between the Company and Canaccord Genuity
(ORAMED PHARMACEUTICALS INC., Filed With SEC on September 5, 2019)
-
Equity Distribution Agreement, dated as of June 17, 2019, by and between Seelos Therapeutics, Inc. and Piper Jaffray & Co
(APRICUS BIOSCIENCES, INC., Filed With SEC on June 18, 2019)